Address
Email address
Phone number
Website
https://www.elitekliinik.eeElite erakliinikElite erakliinik Tartus Sangla 63. Viljatusravi ja günekoloogid, 3D-4D ultraheli, endokrinoloog, nahaarstid, kõrva-nina-kurguarstid, onkoloogid jpm. erialad
Name
OÜ FERTIILSUSE KESKUS
Registry code
10240426
VAT number
EE100042861
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
11.07.1997 (27)
Financial year
01.01-31.12
Capital
22 369.00 €
Activity
74901 - Other professional, scientific and technical activities n.e.c. 68201 - Rental and operating of own or leased real estate
-
-
-
-
-
-
-
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Andrei Sõritsa
| 100% - 22 369.00 EUR | Board member | - | Founder |
| Deniss Sõritsa
| - | Board member | - |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| OÜ Nordik Eksperdid 11059634 | 100% - 2 556.00 EUR | - | - | |
| Fabula Invest OÜ 12349446 | 100% - 2 500.00 EUR | - | - | |
| Formosus Capital OÜ 12746975 | 100% - 2 500.00 EUR | - | - | |
| Clean Kitchen Holdings OÜ 17009583 | 1% - 154.00 EUR | - | - | |
| Tartu linn, Munga tn 3 korteriühistu 80432340 | - | - | - | Founder (without contribution) |
| OÜ Apteek Elite 10850722 | - | - | - | Founder |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q4 | 158 415.28 € | 82 549.25 € | 18 021.24 € | 2 |
| 2024 Q3 | 143 041.01 € | 23 745 € | 9 817.86 € | 3 |
| 2024 Q2 | 117 554.06 € | 40 759.74 € | 13 994.94 € | 2 |
| 2024 Q1 | 176 168.5 € | 62 920.31 € | 18 204.55 € | 3 |
| 2023 Q4 | 161 597.67 € | 44 078.24 € | 15 667.68 € | 3 |
| 2023 Q3 | 44 364.45 € | 30 130.84 € | 11 894.54 € | 3 |
| 2023 Q2 | 317 109.22 € | 21 397.22 € | 7 857.8 € | 4 |
| 2023 Q1 | 60 014.31 € | 38 632.49 € | 12 624.47 € | 2 |
| 2022 Q4 | 127 424.16 € | 4 433.62 € | 10 028.37 € | 2 |
| 2022 Q3 | 242 804.66 € | - | 8 569.95 € | 2 |
| 2022 Q2 | 183 876.93 € | - | 1 473.06 € | 2 |
| 2022 Q1 | 184 267.67 € | 22 015.87 € | 6 045.62 € | 2 |
| 2021 Q4 | 170 658.18 € | 42 728.14 € | 12 211.57 € | 1 |
| 2021 Q3 | 235 153.74 € | 10 996.2 € | 2 311.58 € | 1 |
| 2021 Q2 | 189 854.74 € | 34 648.14 € | 9 738.66 € | 1 |
| 2021 Q1 | 22 609.94 € | 57 085.12 € | 8 668.51 € | 1 |
| 2020 Q4 | 142 690.79 € | 90 837.16 € | 8 013.49 € | 1 |
| 2020 Q3 | 18 611.22 € | 31 639.91 € | 8 975.45 € | - |
| 2020 Q2 | 10 371.21 € | 27 566.44 € | 7 055.59 € | - |
| 2020 Q1 | 121 375.1 € | 11 372.98 € | 641.14 € | - |
